| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |